Nu Skin Enterprises (NYSE: NUS) reported Q3 EPS of $0.97, in-line with the analyst estimate of $0.97. Revenue for the quarter came in at $641.2 million versus the consensus estimate of $683.1 million.

GUIDANCE:

Nu Skin Enterprises sees Q4 2021 EPS of $0.90-$1.00, versus the consensus of $0.96. Nu Skin Enterprises sees Q4 2021 revenue of $645-675 million, versus the consensus of $631.9 million.

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.